Aegon publishes breast cancer CI stats

Published on

Aegon

Aegon UK is sharing previously unpublished figures on breast cancer claims in 2012, as we enter Breast Cancer Awareness Month.

While cancer as a whole made up 60% of all critical illness claims Aegon received in 2012, breast cancer on its own accounted for 23% of these claims – the biggest single cause of critical illness claims that year.

Simon Jacobs, head of underwriting and claims strategy at Aegon UK, said: “These figures combined with the 21 per cent of claims for breast cancer in 2011 demonstrate how important breast cancer awareness is. The good news is that the recent figures released by the Office of National Statistics revealed that women diagnosed with breast cancer are surviving longer.”

In addition, Aegon paid out almost £5.5million in breast cancer critical illness claims in 2012, with an average pay out of £67,500. The average age at claim was 46 years old, with the youngest being only 35 years old.

Breast cancer accounted for 5% of life claims paid in 2012.

Jacobs added: “Early detection and better treatment means that survival rates after a diagnosis of breast cancer are improving. This is clearly reflected in the claims for breast cancer and also creates a stronger case around the importance of critical illness cover.

“Treatment of breast cancer often involves surgery, chemotherapy, hormone therapy or all three. It’s a difficult time for sufferers and their families and with this in mind we make the claims process as simple and quick as possible.”

Jacobs said: “We offer a tele claims process where customers are given a dedicated claims assessor who will complete the claim form for them over the phone and progress the claim. We usually pay the claim within six to seven weeks and we’re continually looking for ways to reduce this further.”

COMMENT ON MORTGAGE SOUP

We want to hear from you!
Leave a comment and get the conversation started.
You need to register to post, so please login or sign up below.

Latest articles

Clydesdale to raise selected residential product transfer rates

Clydesdale is to increase selected residential product transfer rates by up to 0.23%. The changes...

Exeter Leukaemia Fund wins £20,000 MAB grant

The Mortgage Advice Bureau Foundation has awarded its one-off £20,000 Extra Funding Grant to...

No-deposit mortgages carry £73,000 London interest premium

London first-time buyers using a no-deposit mortgage could pay more than £73,000 in additional...

Conveyancing Association begins search for new chair

Nicky Heathcote is to step down as non-executive chair of the Conveyancing Association as...

Overseas funds used by almost one in 10 home buyers

Almost one in 10 home buyers use money originating overseas to fund all or...

Latest publication

Other news

Clydesdale to raise selected residential product transfer rates

Clydesdale is to increase selected residential product transfer rates by up to 0.23%. The changes...

Exeter Leukaemia Fund wins £20,000 MAB grant

The Mortgage Advice Bureau Foundation has awarded its one-off £20,000 Extra Funding Grant to...

No-deposit mortgages carry £73,000 London interest premium

London first-time buyers using a no-deposit mortgage could pay more than £73,000 in additional...